Companies / DICE Therapeutics, Inc.
DICE Therapeutics, Inc.
DICECIK 1645569
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 22, 2023 | Northpond Ventures GP, LLC 10% owner | Sell Open-market sale | Common Stock | $91.58M | -2.0M -75.66% | 633,707 | high |
| Oct 17, 2022 | Ra Capital Management, LLC Director | Buy Open-market buy | Common Stock | $59.86M | +1.6M +31.48% | 6,848,911 | high |
| Jun 22, 2023 | Northpond Ventures GP, LLC 10% owner | Sell Open-market sale | Common Stock | $24.34M | -524K -75.89% | 166,293 | high |
| Sep 17, 2021 | Ra Capital Management, LLC Director | Buy Open-market buy | Common Stock | $22.48M | +1.3M +42.66% | 4,422,504 | high |
| Mar 28, 2023 | Ra Capital Management, LLC Director | Buy Open-market buy | Common Stock | $7.22M | +247K +3.76% | 6,807,839 | high |
| Mar 30, 2023 | Ra Capital Management, LLC Director | Buy Open-market buy | Common Stock | $5.63M | +196K +2.85% | 7,070,205 | high |
| Mar 24, 2023 | Ra Capital Management, LLC Director | Buy Open-market buy | Common Stock | $5.17M | +192K +3.09% | 6,409,928 | high |
| Mar 27, 2023 | Ra Capital Management, LLC Director | Buy Open-market buy | Common Stock | $4.15M | +151K +2.36% | 6,561,060 | high |